Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

N/A

3(60.0%)

Phase 2/3

1(20.0%)

Phase 1/2

1(20.0%)

5Total

N/A(3)

Phase 2/3(1)

Phase 1/2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07619677Not ApplicableNot Yet Recruiting

Feasibility of a Person-centered Nursing Intervention on Adherence and Control in Patients With Arterial Hypertension and Diabetes Mellitus.

Role: lead

NCT06408103Not ApplicableRecruiting

Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad

Role: collaborator

NCT04604665Not ApplicableCompleted

Evaluation of Two Levels of Frequency of Repositioning in the Reduction of Pressure Ulcers

Role: collaborator

NCT02369978Phase 2/3Unknown

CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)

Role: lead

NCT02943486Phase 1/2Unknown

Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2

Role: lead

All 5 trials loaded